Germany vs Singapore: Treatment success rate for patients treated for MDR-TB
Germany
45.0%
in 2022
Singapore
39.0%
in 2022
Germany rank
147th
Singapore rank
150th
Treatment success rate for patients treated for MDR-TB over time
- Germany
- Singapore
How they compare
Germany currently reports 45.0% against 39.0% in Singapore, a difference of 6.0%.
That makes Germany's figure about 1.2 times Singapore's.
The two have swapped places 7 times across 19 shared years of data; in 2002 it was Singapore ahead.
Germany ranks 147th and Singapore ranks 150th of 163 countries.
Across the 3 decades both report, Germany averaged higher in 1 and Singapore in 2.
Head to head by decade
| Decade | Germany | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.3% | 83.7% | 23.3% | Singapore |
| 2010s | 47.8% | 52.9% | 5.1% | Singapore |
| 2020s | 46.3% | 36.7% | 9.7% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Germany or Singapore?
- Germany, at 45.0% against 39.0% in Singapore as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Germany and Singapore?
- 6.0%, with Germany ahead.
- How many years of comparable data are there for Germany and Singapore?
- 19 years are reported by both, from 2002 to 2022.
- How do Germany and Singapore rank globally for treatment success rate for patients treated for mdr-tb?
- Germany ranks 147th and Singapore ranks 150th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.